Navigation Links
Chan Zuckerberg Biohub Choose Geneious For Best Practice NGS Antibody Pipeline
Date:4/8/2019

To support the global fight against existing and emerging infectious disease, the innovative non-profit research center Chan Zuckerberg Biohub (CZ Biohub) has chosen Geneious Biologics to help them analyze and compare human antibody repertoires. The study of antibody repertoires is part of CZ Biohub’s efforts to establish new approaches to inform the discovery of antibody-based diagnostics, new therapies and the design of recombinant protein vaccines. Together with collaborators, CZ Biohub and Geneious are working towards standardizing the analysis and use of immune receptor repertoire data.

Krista McCutcheon Group Leader, Antibody Discovery at CZ Biohub: "The commitment, expertise and collaborative nature of the Geneious team has allowed us to deliver on our internal goal of providing a software pipeline for NGS antibody data analysis and visualization aligned with the best practices in the field."

Geneious Biologics is Biomatters’ cloud-based enterprise software solution for analysis of antibodies and related constructs using NGS or Sanger sequence data. The CZ Biohub are profiling B cell repertoires circulating in human blood in order to understand the history, evolution, memory, and molecular determinants of successful and failed immune responses to pathogens. The Antibody Discovery group then aims to identify and elicit defined specificities of memory B cells to protect diverse human populations around the globe.

Biomatters CEO Brett Ammundsen: “We are delighted to have been chosen by the CZ Biohub to support their mission to solve big health problems, particularly because of their philosophy of using the best scientific tools available. CZ Biohub is setting the standard for the industry and it’s fantastic to be playing a role in that.”

About Geneious and Biomatters
Biomatters empowers its customers with software that transforms biological data into knowledge and actionable insights across the spectrum of biotechnology research and development, including drug discovery, protein engineering and advanced comparative analysis of DNA, RNA and protein sequences. Geneious solutions are created from a deep understanding of customer experience and turn the difficult into the intuitive and easy. That is why Geneious is trusted by over 4,000 companies, universities and institutes all over the globe. https://www.geneious.com/

About the Chan Zuckerberg Biohub
The CZ Biohub is an independent non-profit medical research organization collaborating with the University of California, Berkeley, Stanford University and the University of California, San Francisco. The organization’s goal is to harness the power of science, technology and human capacity to cure, prevent or manage all disease during our children’s lifetime. For more information about the CZ Biohub, visit https://czbiohub.org.

Read the full story at https://www.prweb.com/releases/chan_zuckerberg_biohub_choose_geneious_for_best_practice_ngs_antibody_pipeline/prweb16226357.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related biology technology :

1. Diabetes Research Institute Successfully Transplants First Patient In Pilot BioHub Trial
2. DaVita Clinical Research and Prism Clinical Research Choose Verified Clinical Trials to Prevent Duplicate Enrollment in Clinical Trials
3. Boston-Based CIC Chooses uCity Square for Newest Expansion Location
4. ChooseATL and the Metro Atlanta Chamber Launch New Speaker Series, JAM Session
5. Boehringer Ingelheim Chooses Genedata Selector(TM) for Cell Line Development and Cell Culture Optimization
6. Merck Serono Chooses Genedata Biologics to Streamline Antibody Discovery Processes
7. Physician Group Practice Chooses e2b teknologies to Support Its Upgrade to Sage 100 ERP 2014
8. Namdhari Seeds, One of India’s Largest Seed Companies, Chooses Phenome Networks for Plant Breeding Management
9. Michigan State Police Chooses More Software from STACS DNA
10. PrimeSource Chooses SoundConnect as Collaboration Provider
11. Extreme Sport Athletes Choose the Rebound® TENS Unit at Clash at Clairemont 8
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2019)... Calif. (PRWEB) , ... August 27, 2019 , ... Dr. ... She recently opened North Peninsula Veterinary Surgical Group , a new surgical ... however there are plans to expand and add more veterinary specialists as the practice ...
(Date:8/23/2019)... ... August 22, 2019 , ... An ... and is scheduled to broadcast 4Q/2019. Check your local listings for more information. ... for generic drug delivery. Focusing on therapeutics for children and the elderly, viewers ...
(Date:8/8/2019)... ... August 08, 2019 , ... ... for sales and service organizations, today announced that the company’s Studio Intelligent Virtual ... the IVA market . Inference will officially accept the award at Frost & ...
(Date:8/6/2019)... Ill. (PRWEB) , ... August 05, 2019 , ... ... that Jason Casarella has been recognized as a distinguished leader by PharmaVOICE magazine, ... featured in an article in the magazine’s July/August special issue. , As the ...
Breaking Biology Technology:
(Date:9/17/2019)... CA (PRWEB) , ... September 17, 2019 , ... ... recently presented at the 27th Series of the Australia Society of Implant Dentistry ... Implant Surgeon’s Perspective,” was part of the Surgical Aspects of Modern Implant Dentistry ...
(Date:9/11/2019)... ... September 09, 2019 , ... Greenberg Traurig, LLP attorneys ... will speak at DeviceTalks Minnesota, Sept. 9-10, at the Hyatt Regency, Minneapolis. Greenberg ... Life Sciences & Medical Technology Group have been featured speakers at every DeviceTalks ...
(Date:9/8/2019)... ... 06, 2019 , ... The Board of Directors of Cardea ... respective companies to proceed with a proposed business combination. After the closing, ... series of products leveraging the CRISPR-Chip technology. The closing of the proposed ...
Breaking Biology News(10 mins):